¥2,438.00
1.27%
Tokyo, Sep 25, 03:15 pm JST. Closed.
ISIN
JP3197600004
Symbol
4528

Ono Pharmaceutical Target price 2026 - Analyst rating & recommendation

Ono Pharmaceutical Classifications & Recommendation

Buy
15%
Hold
50%
Sell
35%

Ono Pharmaceutical Price Target

Target Price ¥2,499.00
Price ¥2,442.00
Potential
Number of Estimates 15
15 Analysts have issued a price target Ono Pharmaceutical 2027 . The average Ono Pharmaceutical target price is ¥2,499.00. This is higher than the current stock price. The highest price target is
¥3,360.00 37.59%
register free of charge
, the lowest is
¥2,070.50 15.21%
register free of charge
.
A rating was issued by 20 analysts: 3 Analysts recommend Ono Pharmaceutical to buy, 10 to hold and 7 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Ono Pharmaceutical stock has an average upside potential 2027 of . Most analysts recommend the Ono Pharmaceutical stock at Hold.

Sales and Margin forecast 2027, 2028 & 2029

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Mar '26 2027
Estimates
Revenue Billion ¥ 515.79 462.73
5.94% 10.29%
EBITDA Margin 18.48% 29.51%
38.63% 59.68%
Net Margin 13.53% 17.00%
31.59% 25.68%

15 Analysts have issued a sales forecast Ono Pharmaceutical 2027 . The average Ono Pharmaceutical sales estimate is

¥463b
unlock
. This is
8.26% lower
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
¥495b 1.95%
unlock
, the lowest is
¥435b 13.70%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2026 ¥516b 5.94%
2027
¥463b 10.29%
unlock
2028
¥453b 2.11%
unlock
2029
¥465b 2.76%
unlock

14 Analysts have issued an Ono Pharmaceutical EBITDA forecast 2027. The average Ono Pharmaceutical EBITDA estimate is

¥137b
unlock
. This is
1.34% lower
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
¥173b 24.89%
unlock
, the lowest is
¥109b 20.93%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2026 ¥95.3b 46.87%
2027
¥137b 43.24%
unlock
2028
¥119b 13.03%
unlock
2029
¥122b 2.85%
unlock

EBITDA Margin

2026 18.48% 38.63%
2027
29.51% 59.68%
unlock
2028
26.22% 11.15%
unlock
2029
26.24% 0.08%
unlock

15 Ono Pharmaceutical Analysts have issued a net profit forecast 2027. The average Ono Pharmaceutical net profit estimate is

¥78.7b
unlock
. This is
3.17% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
¥107b 40.47%
unlock
, the lowest is
¥69.3b 9.16%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2026 ¥69.8b 39.40%
2027
¥78.7b 12.75%
unlock
2028
¥67.5b 14.15%
unlock
2029
¥71.4b 5.71%
unlock

Net Margin

2026 13.53% 31.59%
2027
17.00% 25.68%
unlock
2028
14.91% 12.29%
unlock
2029
15.34% 2.88%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2027, 2028 & 2029

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Mar '26 2027
Estimates
Earnings Per Share ¥ 148.48 167.40
39.38% 12.74%
P/E 14.38
EV/Sales 2.20

15 Analysts have issued a Ono Pharmaceutical forecast for earnings per share. The average Ono Pharmaceutical EPS is

¥167.40
unlock
. This is
3.17% higher
unlock
than earnings per share in the financial year 2026. The highest EPS forecast is
¥227.92 40.47%
unlock
, the lowest is
¥147.39 9.16%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2026 ¥148.48 39.38%
2027
¥167.40 12.74%
unlock
2028
¥143.71 14.15%
unlock
2029
¥151.92 5.71%
unlock

P/E ratio

Current 14.84 20.72%
2027
14.38 3.09%
unlock
2028
16.75 16.48%
unlock
2029
15.85 5.37%
unlock

Based on analysts' sales estimates for 2027, the Ono Pharmaceutical stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 2.02 24.69%
2027
2.20 8.90%
unlock
2028
2.25 2.15%
unlock
2029
2.19 2.69%
unlock

P/S ratio

Current 2.22 36.79%
2027
2.42 9.00%
unlock
2028
2.48 2.15%
unlock
2029
2.41 2.68%
unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today